Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GM2A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | PRR16 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | FSTL3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | RPL34 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | S100Z | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | NUP50 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | KLHL15 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | PGBD5 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | C2orf70 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | BLK | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |